ClinicalTrials.Veeva

Menu

Crystalloids for AKI in Shock Patients

S

Southeast University, China

Status

Unknown

Conditions

Shock

Treatments

Drug: Fluid resuscitation

Study type

Interventional

Funder types

Other

Identifiers

NCT03188614
2017ZDSYLL018P

Details and patient eligibility

About

Fluid resuscitation is important in shock therapy, but the choice of fluids, especially the choice of crystalloid is under debate. It is said that normal saline is related to hyperchloremia, which might lead to acute kidney injury. Thus the hypothesis of the study is to explicit whether balanced salt solution could reduce the incidence of acute kidney injury when compared with normal saline.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Shock patients

Exclusion criteria

  • History of chronic renal failure

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 2 patient groups, including a placebo group

Normal saline group
Placebo Comparator group
Description:
Shock patients who resuscitated with normal saline were enrolled between June, 2015-June.2016.
Treatment:
Drug: Fluid resuscitation
Balanced solution group
Experimental group
Description:
Shock patients who resuscitated with balanced solution were enrolled after June, 2016.
Treatment:
Drug: Fluid resuscitation

Trial contacts and locations

0

Loading...

Central trial contact

Jingyuan Xu, Docotor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems